AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dolbinac SP 50mg/325mg/15mg Tablet

Prescription Icon
Prescription Required

Marketer

Treatwell Biotech

Salt Composition

Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)

Overview Dolbinac SP 50mg/325mg/15mg Tablet

Analgesic Tri-Component Tablets (50mg/325mg/15mg) offer relief from moderate pain and fever. Effective for muscle aches, back pain, arthralgia, dysmenorrhea, and odontalgia, these tablets should be ingested with food to minimize gastrointestinal upset. Dosage and treatment length are determined by individual response and the underlying condition. Continue medication as directed, even with symptom improvement, until your physician advises discontinuation. Common, mild side effects may include nausea, emesis, abdominal pain, dyspepsia, and pyrosis. Persistent or worsening side effects warrant medical attention; your doctor may offer management strategies. Minimize dosage while achieving symptom control. Prior to use, disclose all pre-existing medical conditions and medications to your doctor, as interactions are possible. Exercise caution if you have a history of alcohol abuse, hepatic impairment, or renal disease. Pregnant or lactating individuals should seek medical counsel before use.

Primary Ingredients of Dolbinac SP 50mg/325mg/15mg Tablet

The provided text is "undefined," so no rephrasing is possible.

Uses of Dolbinac SP 50mg/325mg/15mg Tablet

Analgesia

Major Benefits of Dolbinac SP 50mg/325mg/15mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Dolbinac SP 50mg/325mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Dolbinac SP 50mg/325mg/15mg Tablet:

  • Nausea
  • Vomiting
  • Stomach pain
  • Indigestion
  • Heartburn
  • Loss of appetite
  • Diarrhea

How to use Dolbinac SP 50mg/325mg/15mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Dolbinac SP 50mg/325mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Dolbinac SP 50mg/325mg/15mg Tablet works:

Each Dolbinac SP 50mg/325mg/15mg tablet unites diclofenac, paracetamol, and serratiopeptidase to alleviate pain. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic paracetamol, reduce pain and fever by inhibiting the production of specific pain and fever-inducing brain chemicals. Serratiopeptidase, an enzyme, accelerates healing by degrading damaged proteins within inflamed tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dolbinac SP 50mg/325mg/15mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Dolbinac SP 50mg/325mg/15mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Dolbinac SP 50mg/325mg/15mg tablets while breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving ability may be impaired by Dolbinac SP 50mg/325mg/15mg Tablets, which can induce side effects such as headaches, blurred vision, dizziness, or drowsiness in certain individuals.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Dolbinac SP 50mg/325mg/15mg tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Dolbinac SP 50mg/325mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Dolbinac SP 50mg/325mg/15mg tablets are contraindicated in individuals with severe or active liver disease.

What if you forget to take Dolbinac SP 50mg/325mg/15mg Tablet :

Should you forget to take a Dolbinac SP 50mg/325mg/15mg Tablet, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dolbinac SP 50mg/325mg/15mg Tablet

LabelValue
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Dolbinac SP 50mg/325mg/15mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Dolbinac SP 50mg/325mg/15mg tablets combine diclofenac, paracetamol, and serratiopeptidase to relieve pain and inflammation by reducing pain- and inflammation-causing chemicals.
Dolbinac SP 50mg/325mg/15mg Tablets are generally safe, but some patients may experience side effects such as nausea, vomiting, stomach pain, heartburn, or diarrhea. Report any persistent side effects to your doctor immediately.
Dolbinac SP 50mg/325mg/15mg Tablets are typically used for short-term pain relief and can be stopped once pain subsides. Your doctor, however, may advise continuing treatment.
Nausea and vomiting are possible side effects of Dolbinac SP 50mg/325mg/15mg Tablets. Taking the tablets with milk, food, or antacids may help prevent nausea. Avoid fatty or fried foods. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Dizziness (lightheadedness, faintness, weakness, unsteadiness) is a possible side effect of $ame for some individuals. Rest is advised if dizziness occurs; resume activity only when feeling better. Avoid operating machinery or driving.
Dolbinac SP 50mg/325mg/15mg Tablets are contraindicated in patients allergic to its components or other painkillers (NSAIDs). Patients with a history of stomach ulcers, active or recurrent ulcer/bleeding, heart failure, high blood pressure, liver, or kidney disease should avoid this medication.
Dolbinac SP 50mg/325mg/15mg Tablets may be used concurrently with vitamin B-complex preparations. Dolbinac SP provides pain relief, while the vitamin B-complex addresses potential vitamin deficiencies contributing to your symptoms.
Avoid taking Dolbinac SP 50mg/325mg/15mg tablets for stomach pain without a doctor's consultation. This medication may increase stomach acid, potentially worsening undiagnosed conditions.
Exceeding the recommended dose of Dolbinac SP 50mg/325mg/15mg tablets increases the risk of side effects. For persistent or worsening pain despite taking the prescribed dose, consult your physician.
Dolbinac SP 50mg/325mg/15...
73
MRP 85
14% off